BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27515048)

  • 1. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
    Achek A; Yesudhas D; Choi S
    Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics.
    Gomariz RP; Gutiérrez-Cañas I; Arranz A; Carrión M; Juarranz Y; Leceta J; Martínez C
    Curr Pharm Des; 2010; 16(9):1063-80. PubMed ID: 20030612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of toll-like receptors in inflammatory bowel disease.
    Kordjazy N; Haj-Mirzaian A; Haj-Mirzaian A; Rohani MM; Gelfand EW; Rezaei N; Abdolghaffari AH
    Pharmacol Res; 2018 Mar; 129():204-215. PubMed ID: 29155256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in the development of Toll-like receptor (TLR) antagonists.
    Patra MC; Choi S
    Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors as potential therapeutic targets for multiple diseases.
    Zuany-Amorim C; Hastewell J; Walker C
    Nat Rev Drug Discov; 2002 Oct; 1(10):797-807. PubMed ID: 12360257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation.
    Ishihara S; Rumi MA; Ortega-Cava CF; Kazumori H; Kadowaki Y; Ishimura N; Kinoshita Y
    Curr Pharm Des; 2006; 12(32):4215-28. PubMed ID: 17100624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-Like Receptors, Infections, and Rheumatoid Arthritis.
    Arleevskaya MI; Larionova RV; Brooks WH; Bettacchioli E; Renaudineau Y
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):172-181. PubMed ID: 31144208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.
    Ofodile ON
    J Ind Microbiol Biotechnol; 2007 Dec; 34(12):751-62. PubMed ID: 17876621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.
    van Egmond M; Vidarsson G; Bakema JE
    Immunol Rev; 2015 Nov; 268(1):311-27. PubMed ID: 26497530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Toll-like receptors with small molecule agents.
    Wang X; Smith C; Yin H
    Chem Soc Rev; 2013 Jun; 42(12):4859-66. PubMed ID: 23503527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Toll-like receptor signalling in the pathogenesis of arthritis.
    Brentano F; Kyburz D; Schorr O; Gay R; Gay S
    Cell Immunol; 2005 Feb; 233(2):90-6. PubMed ID: 15963480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Toll-like receptors in infection and immunity: clinical implications.
    Cristofaro P; Opal SM
    Drugs; 2006; 66(1):15-29. PubMed ID: 16398566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor modulators: a patent review (2006-2010).
    Basith S; Manavalan B; Lee G; Kim SG; Choi S
    Expert Opin Ther Pat; 2011 Jun; 21(6):927-44. PubMed ID: 21406035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
    Gooshe M; Abdolghaffari AH; Gambuzza ME; Rezaei N
    Rev Neurosci; 2014; 25(5):713-39. PubMed ID: 24914714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signaling in parasitic infections.
    Ashour DS
    Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of toll-like receptors by insulin.
    Tilich M; Arora RR
    Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.